Filing search / Cellectar Biosciences, Inc. / "Purpose" / Page 3

8-K

EX-1.1

xkz0c8n kdmk4ql87

25 Oct 22

Entry into a Material Definitive Agreement

5:03pm

8-K

EX-4.2

f2rvwn971xkxpi0e

25 Oct 22

Entry into a Material Definitive Agreement

5:03pm

8-K

EX-10.3

wbontlhuu orgpsvat

25 Oct 22

Entry into a Material Definitive Agreement

5:03pm

8-K

EX-10.1

gmt b6qwwvouy

25 Oct 22

Entry into a Material Definitive Agreement

5:03pm

8-K

EX-10.2

gexijsn

25 Oct 22

Entry into a Material Definitive Agreement

5:03pm

8-K

EX-4.1

ptvms5u1

25 Oct 22

Entry into a Material Definitive Agreement

5:03pm

424B5

27w9tiyb3

24 Oct 22

Prospectus supplement for primary offering

4:36pm

424B5

b3t sbr1usb3

20 Oct 22

Prospectus supplement for primary offering

4:37pm

S-8

uz5mo2p

5 Aug 22

Registration of securities for employees

4:32pm

DEFR14A

6vrgc 2rdbw9p53ic

7 Jun 22

Revised proxy

5:09pm

8-K

EX-10.1

vomxqovm nxexn

25 Feb 22

Cellectar Biosciences Announces Executive Leadership Changes

4:05pm

8-K

vpi33q

2 Nov 21

Cellectar Appoints Laurence Reilly, M.D., LL.M Interim Chief Medical Officer

4:06pm